Shen L - Search Results

1

Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides.

Zhao Y, Wang S, Fei W, Feng Y, Shen L, Yang X, Wang M, Wu M. Zhao Y, et al. Among authors: shen l. Int J Mol Sci. 2021 May 26;22(11):5630. doi: 10.3390/ijms22115630. Int J Mol Sci. 2021. PMID: 34073203 Free PMC article.

2

Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.

Hui H, Zhang X, Li H, Liu X, Shen L, Zhu Y, Xu J, Guo Q, Lu N. Hui H, et al. Among authors: shen l. J Cancer Res Clin Oncol. 2016 Jul;142(7):1449-59. doi: 10.1007/s00432-016-2160-1. Epub 2016 Apr 16. J Cancer Res Clin Oncol. 2016. PMID: 27085528

3

Wogonoside induces depalmitoylation and translocation of PLSCR1 and N-RAS in primary acute myeloid leukaemia cells.

Li H, Yu X, Liu X, Hu P, Shen L, Zhou Y, Zhu Y, Li Z, Hui H, Guo Q, Xu J. Li H, et al. Among authors: shen l. J Cell Mol Med. 2018 Apr;22(4):2117-2130. doi: 10.1111/jcmm.13481. Epub 2018 Jan 29. J Cell Mol Med. 2018. PMID: 29377576 Free PMC article.

4

Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells.

Li H, Lu N, Yu X, Liu X, Hu P, Zhu Y, Shen L, Xu J, Li Z, Guo Q, Hui H. Li H, et al. Among authors: shen l. Carcinogenesis. 2018 Oct 8;39(10):1292-1303. doi: 10.1093/carcin/bgy004. Carcinogenesis. 2018. PMID: 29346508

5

Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer.

Shen L, Zhang LL, Li H, Liu X, Yu XX, Hu P, Hui H, Guo QL, Zhang S. Shen L, et al. Oncotarget. 2017 Jul 25;8(30):49395-49408. doi: 10.18632/oncotarget.17218. Oncotarget. 2017. PMID: 28472762 Free PMC article.

6

Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.

Wang M, Cheng L, Xiang Q, Gao Z, Ding Y, Xie H, Chen X, Yu P, Shen L. Wang M, et al. Among authors: shen l. Heliyon. 2023 Oct 18;9(10):e21158. doi: 10.1016/j.heliyon.2023.e21158. eCollection 2023 Oct. Heliyon. 2023. PMID: 37928399 Free PMC article.

7

Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1.

Lai Q, Yuan G, Shen L, Zhang L, Fu F, Liu Z, Zhang Y, Kou J, Liu S, Yu B, Li F. Lai Q, et al. Among authors: shen l. Basic Res Cardiol. 2021 Jan 23;116(1):3. doi: 10.1007/s00395-021-00844-0. Basic Res Cardiol. 2021. PMID: 33484341

8

Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway.

Cheng S, Zhang X, Feng Q, Chen J, Shen L, Yu P, Yang L, Chen D, Zhang H, Sun W, Chen X. Cheng S, et al. Among authors: shen l. Life Sci. 2019 Jun 15;227:82-93. doi: 10.1016/j.lfs.2019.04.040. Epub 2019 Apr 17. Life Sci. 2019. PMID: 31004658

9

Integrated bioinformatics and experiment revealed that cuproptosis is the potential common pathogenesis of three kinds of primary cardiomyopathy.

Wang M, Xu X, Li J, Gao Z, Ding Y, Chen X, Xiang Q, Shen L. Wang M, et al. Among authors: shen l. Aging (Albany NY). 2023 Dec 11;15(23):14210-14241. doi: 10.18632/aging.205298. Epub 2023 Dec 11. Aging (Albany NY). 2023. PMID: 38085668 Free PMC article.

10

miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury.

Sun W, Shi R, Guo J, Wang H, Shen L, Shi H, Yu P, Chen X. Sun W, et al. Among authors: shen l. Front Cardiovasc Med. 2021 Aug 13;8:663832. doi: 10.3389/fcvm.2021.663832. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34485394 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,660 results

Search Page

Filters